A detailed history of Loring Wolcott & Coolidge Fiduciary Advisors LLP transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Loring Wolcott & Coolidge Fiduciary Advisors LLP holds 59,098 shares of EW stock, worth $4.17 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
59,098
Previous 105,844 44.16%
Holding current value
$4.17 Million
Previous $9.78 Million 60.12%
% of portfolio
0.04%
Previous 0.09%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 25, 2024

SELL
$59.7 - $93.78 $2.79 Million - $4.38 Million
-46,746 Reduced 44.16%
59,098 $3.9 Million
Q2 2024

Jul 17, 2024

SELL
$84.3 - $94.31 $2.31 Million - $2.59 Million
-27,458 Reduced 20.6%
105,844 $9.78 Million
Q1 2024

Apr 23, 2024

SELL
$72.54 - $95.56 $3.81 Million - $5.03 Million
-52,589 Reduced 28.29%
133,302 $12.7 Million
Q4 2023

Feb 01, 2024

SELL
$61.71 - $77.76 $17.2 Million - $21.7 Million
-279,095 Reduced 60.02%
185,891 $14.2 Million
Q3 2023

Nov 03, 2023

SELL
$69.28 - $93.38 $29.1 Million - $39.2 Million
-420,027 Reduced 47.46%
464,986 $32.2 Million
Q2 2023

Aug 01, 2023

SELL
$81.41 - $94.33 $4.39 Million - $5.08 Million
-53,897 Reduced 5.74%
885,013 $83.5 Million
Q1 2023

May 02, 2023

SELL
$74.26 - $84.51 $2.35 Million - $2.67 Million
-31,638 Reduced 3.26%
938,910 $77.7 Million
Q4 2022

Mar 02, 2023

BUY
$68.3 - $87.44 $576,656 - $738,255
8,443 Added 0.88%
970,548 $72.4 Million
Q4 2022

Feb 14, 2023

SELL
$68.3 - $87.44 $1.24 Million - $1.58 Million
-18,097 Reduced 1.85%
962,105 $77 Million
Q3 2022

Oct 25, 2022

BUY
$82.37 - $107.29 $1.13 Million - $1.47 Million
13,709 Added 1.42%
980,202 $81 Million
Q2 2022

Jul 26, 2022

BUY
$86.5 - $128.27 $134,075 - $198,818
1,550 Added 0.16%
966,493 $91.9 Million
Q1 2022

Apr 13, 2022

BUY
$101.96 - $128.34 $218,194 - $274,647
2,140 Added 0.22%
964,943 $114 Million
Q4 2021

Feb 14, 2022

SELL
$106.37 - $130.68 $1.79 Million - $2.2 Million
-16,810 Reduced 1.72%
962,803 $125 Million
Q3 2021

Nov 12, 2021

BUY
$102.91 - $122.75 $257,480 - $307,120
2,502 Added 0.26%
979,613 $111 Million
Q2 2021

Aug 13, 2021

SELL
$83.84 - $104.76 $136,659 - $170,758
-1,630 Reduced 0.17%
977,111 $101 Million
Q1 2021

Apr 14, 2021

BUY
$78.68 - $90.67 $888,611 - $1.02 Million
11,294 Added 1.17%
978,741 $81.9 Million
Q4 2020

Jan 14, 2021

BUY
$71.69 - $91.23 $10.4 Million - $13.3 Million
145,374 Added 17.68%
967,447 $88.3 Million
Q3 2020

Oct 15, 2020

BUY
$67.19 - $87.44 $21.4 Million - $27.8 Million
317,785 Added 63.02%
822,073 $65.6 Million
Q2 2020

Jul 30, 2020

BUY
$57.54 - $76.95 $23.6 Million - $31.5 Million
409,849 Added 433.98%
504,288 $34.9 Million
Q1 2020

Apr 15, 2020

BUY
$52.41 - $81.0 $195,594 - $302,292
3,732 Added 4.11%
94,439 $17.8 Million
Q4 2019

Jan 22, 2020

BUY
$71.7 - $82.09 $140,316 - $160,650
1,957 Added 2.21%
90,707 $21.2 Million
Q3 2019

Nov 05, 2019

BUY
$61.55 - $75.43 $375,270 - $459,896
6,097 Added 7.38%
88,750 $19.5 Million
Q2 2019

Aug 09, 2019

BUY
$55.74 - $64.41 $353,614 - $408,617
6,344 Added 8.31%
82,653 $15.3 Million
Q1 2019

Apr 08, 2019

BUY
$47.89 - $64.05 $65,561 - $87,684
1,369 Added 1.83%
76,309 $14.6 Million
Q4 2018

Feb 13, 2019

BUY
$46.41 - $56.94 $119,923 - $147,132
2,584 Added 3.57%
74,940 $11.5 Million
Q3 2018

Oct 31, 2018

SELL
$45.7 - $58.03 $38,845 - $49,325
-850 Reduced 1.16%
72,356 $12.6 Million
Q2 2018

Aug 07, 2018

BUY
$42.45 - $51.3 $2,971 - $3,591
70 Added 0.1%
73,206 $10.7 Million
Q1 2018

Apr 20, 2018

BUY
$37.19 - $47.45 $2.21 Million - $2.82 Million
59,476 Added 435.4%
73,136 $10.2 Million
Q4 2017

Feb 08, 2018

BUY
$33.79 - $39.39 $187,196 - $218,220
5,540 Added 68.23%
13,660 $1.54 Million
Q3 2017

Oct 27, 2017

BUY
$36.29 - $38.83 $193,933 - $207,507
5,344 Added 192.51%
8,120 $888,000
Q2 2017

Aug 07, 2017

BUY
N/A
2,776
2,776 $0

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $43.6B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Loring Wolcott & Coolidge Fiduciary Advisors LLP Portfolio

Follow Loring Wolcott & Coolidge Fiduciary Advisors LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Loring Wolcott & Coolidge Fiduciary Advisors LLP, based on Form 13F filings with the SEC.

News

Stay updated on Loring Wolcott & Coolidge Fiduciary Advisors LLP with notifications on news.